SIGNATURE stems from the H2020 IMI2-funded 3TR project, a transdisciplinary consortium to improve knowledge of the mechanisms related to treatment in seven different immune-mediated, allergic and inflammatory diseases. SIGNATURE will make use of the 3TR collected multi-dimensional molecular data from the recruited patients to go further in the research.

 

Call: MSCA-DN

Funding entity: Comisión Europea

Center: GENYO

Time of implementation: 01/01/2023 – 31/12/2026

Principal Investigator: Dr. Marta E. Alarcón and Dr. Concepción Marañón 

More information: https://www.dn-signature.eu/ 

 

Other international projects

Subscribe to our newsletter